前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：202202259718784081
整理番号：22A1171528
大規模実世界コホート研究における移植関連血栓性微小血管症に対する治療血漿交換の治療転帰と有効性【JST・京大機械翻訳】
Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort study
Yang Li-Ping
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Yang Li-Ping
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Yang Li-Ping
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Yang Li-Ping
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Zhao Peng
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Zhao Peng
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Zhao Peng
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Zhao Peng
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Wu Ye-Jun
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Wu Ye-Jun
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Wu Ye-Jun
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Wu Ye-Jun
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Fu Hai-Xia
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Fu Hai-Xia
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Fu Hai-Xia
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Fu Hai-Xia
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
He Yun
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
He Yun
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
He Yun
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
He Yun
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Mo Xiao-Dong
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Mo Xiao-Dong
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Mo Xiao-Dong
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Mo Xiao-Dong
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Lv Meng
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Lv Meng
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Lv Meng
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Lv Meng
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Wang Feng-Rong
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Wang Feng-Rong
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Wang Feng-Rong
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Wang Feng-Rong
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Yan Chen-Hua
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Yan Chen-Hua
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Yan Chen-Hua
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Yan Chen-Hua
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Chen Yu-Hong
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Chen Yu-Hong
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Chen Yu-Hong
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Chen Yu-Hong
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Chang Ying-Jun
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Chang Ying-Jun
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Chang Ying-Jun
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Chang Ying-Jun
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Xu Lan-Ping
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Xu Lan-Ping
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Xu Lan-Ping
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Xu Lan-Ping
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Liu Kai-Yan
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Liu Kai-Yan
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Liu Kai-Yan
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Liu Kai-Yan
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Huang Xiao-Jun
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Huang Xiao-Jun
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Huang Xiao-Jun
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Huang Xiao-Jun
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Zhang Xiao-Hui
(Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China)
,
Zhang Xiao-Hui
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Zhang Xiao-Hui
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Zhang Xiao-Hui
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
資料名：
Bone Marrow Transplantation
(Bone Marrow Transplantation)
巻： 57 号： 4 ページ： 554-561 発行年： 2022年
JST資料番号： W4117A ISSN： 0268-3369 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： ドイツ (DEU) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。